Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 442

1.

Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study.

Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group, the Royal Free Hospital Clinic Cohort, and the INSIGHT, SMART, and ESPRIT study groups.

PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015 Mar.

2.

Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the d: a: d study.

Bruyand M, Ryom L, Shepherd L, Fatkenheuer G, Grulich A, Reiss P, de Wit S, D Arminio Monforte A, Furrer H, Pradier C, Lundgren J, Sabin C; D:A:D study group.

J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):568-77. doi: 10.1097/QAI.0000000000000523.

PMID:
25763785
3.

Research in action: from AIDS to global health to impact. A symposium in recognition of the scientific contributions of Professor Joep Lange.

Boender TS, Barré-Sinoussi F, Cooper D, Goosby E, Hankins C, Heidenrijk M, de Jong M, Kazatchkine M, Laoye F, Merson M, Reiss P, Rinke de Wit TF, Rogo K, Schellekens O, Schultsz C, Sigaloff KC, Simon J, Zewdie D.

Antivir Ther. 2015;20(1):101-8. doi: 10.3851/IMP2946. Epub 2015 Feb 18. No abstract available.

PMID:
25691450
4.

Prospects of nanoscience with nanocrystals.

Kovalenko MV, Manna L, Cabot A, Hens Z, Talapin DV, Kagan CR, Klimov VI, Rogach AL, Reiss P, Milliron DJ, Guyot-Sionnnest P, Konstantatos G, Parak WJ, Hyeon T, Korgel BA, Murray CB, Heiss W.

ACS Nano. 2015 Feb 24;9(2):1012-57. doi: 10.1021/nn506223h. Epub 2015 Jan 22.

PMID:
25608730
5.

Risk of non-AIDS-defining events among HIV-infected patients not yet on antiretroviral therapy.

Zhang S, van Sighem A, Kesselring A, Gras L, Prins J, Hassink E, Kauffmann R, Richter C, de Wolf F, Reiss P; ATHENA national observational HIV cohort study.

HIV Med. 2015 Jan 21. doi: 10.1111/hiv.12202. [Epub ahead of print]

PMID:
25604160
6.

Diminished Impact of Ethnicity as a Risk Factor for Chronic Kidney Disease in the Current HIV Treatment Era.

Schoffelen AF, Smit C, van Lelyveld SF, Vogt L, Bauer MP, Reiss P, Hoepelman AI, Barth RE; on behalf of the ATHENA National Observational HIV Cohort.

J Infect Dis. 2015 Jan 18. pii: jiv026. [Epub ahead of print]

PMID:
25601941
7.

Enhanced charge separation in ternary P3HT/PCBM/CuInS2 nanocrystals hybrid solar cells.

Lefrançois A, Luszczynska B, Pepin-Donat B, Lombard C, Bouthinon B, Verilhac JM, Gromova M, Faure-Vincent J, Pouget S, Chandezon F, Sadki S, Reiss P.

Sci Rep. 2015 Jan 15;5:7768. doi: 10.1038/srep07768.

8.

Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection.

Su T, Schouten J, Geurtsen GJ, Wit FW, Stolte IG, Prins M, Portegies P, Caan MW, Reiss P, Majoie CB, Schmand BA; AGEhIV Cohort Study Group.

AIDS. 2015 Mar 13;29(5):547-57. doi: 10.1097/QAD.0000000000000573.

PMID:
25587908
9.

Quantile rank maps: A new tool for understanding individual brain development.

Chen H, Kelly C, Xavier Castellanos F, He Y, Zuo XN, Reiss PT.

Neuroimage. 2015 Jan 10. pii: S1053-8119(15)00013-0. doi: 10.1016/j.neuroimage.2014.12.082. [Epub ahead of print]

PMID:
25585020
10.

Working towards a consensus for antibody validation.

Reiss PD, Min D, Leung MY.

F1000Res. 2014 Nov 5;3:266. doi: 10.12688/f1000research.5668.1. eCollection 2014.

11.

Poorer Cognitive Performance in Perinatally HIV-Infected Children Versus Healthy Socioeconomically Matched Controls.

Cohen S, Ter Stege JA, Geurtsen GJ, Scherpbier HJ, Kuijpers TW, Reiss P, Schmand B, Pajkrt D.

Clin Infect Dis. 2015 Apr 1;60(7):1111-9. doi: 10.1093/cid/ciu1144. Epub 2014 Dec 16.

PMID:
25516183
12.

Internal urethrotomy in patients with recurrent urethral stricture after buccal mucosa graft urethroplasty.

Rosenbaum CM, Schmid M, Ludwig TA, Kluth LA, Reiss P, Dahlem R, Engel O, Chun FK, Riechardt S, Fisch M, Ahyai SA.

World J Urol. 2014 Nov 27. [Epub ahead of print]

PMID:
25428791
13.

Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.

Helleberg M, May MT, Ingle SM, Dabis F, Reiss P, Fätkenheuer G, Costagliola D, d'Arminio A, Cavassini M, Smith C, Justice AC, Gill J, Sterne JA, Obel N.

AIDS. 2015 Jan 14;29(2):221-9. doi: 10.1097/QAD.0000000000000540.

14.

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe.

Mocroft A, Ryom L, Lapadula G, Reiss P, Blaxhult A, Furrer H, Kutsyna G, Gatell J, Begovac J, Kirk O, Lundgren J.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19561. doi: 10.7448/IAS.17.4.19561. eCollection 2014.

15.

Patients' willingness to take separate component antiretroviral therapy regimens for HIV in the Netherlands.

Engelhard E, Smith C, Vervoort S, Kroon F, Brinkman K, Nieuwkerk P, Reiss P, Geerlings S.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19536. doi: 10.7448/IAS.17.4.19536. eCollection 2014.

16.

Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study.

Hatleberg CI, Ryom L, El-Sadr W, Mocroft A, Reiss P, de Wit S, Dabis F, Pradier C, Monforte Ad, Rickenbach M, Law M, Lundgren J, Sabin C.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19516. doi: 10.7448/IAS.17.4.19516. eCollection 2014.

17.

A clinically useful risk-score for chronic kidney disease in HIV infection.

Mocroft A, Lundgren J, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Heuhaus J, Fux C, Moranne O, Morlat P, Johnson M, Ryom L; Data on Adverse Events (D:A:D) study group, the Royal Free Hospital Clinic Cohort and the INSIGHT study group.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19514. doi: 10.7448/IAS.17.4.19514. eCollection 2014.

18.

Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D study.

Smith C, Ryom L, Monforte Ad, Reiss P, Mocroft A, El-Sadr W, Weber R, Law M, Sabin C, Lundgren J.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19512. doi: 10.7448/IAS.17.4.19512. eCollection 2014.

19.

Regional differences in self-reported HIV care and management in the EuroSIDA study.

Laut KG, Mocroft A, Lazarus J, Reiss P, Rockstroh J, Karpov I, Rakhmanova A, Knysz B, Moreno S, Gargalianos P, Lundgren J, Kirk O; Eurosida in Eurocoord.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19504. doi: 10.7448/IAS.17.4.19504. eCollection 2014.

20.

Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study.

Mutwa PR, Boer KR, Asiimwe-Kateera B, Tuyishimire D, Muganga N, Lange JM, van de Wijgert J, Asiimwe A, Reiss P, Geelen SP.

PLoS One. 2014 Nov 3;9(11):e111948. doi: 10.1371/journal.pone.0111948. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk